enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Prostate cancer screening - Wikipedia

   en.wikipedia.org/wiki/Prostate_cancer_screening

   Prostate cancer antigen 3 is a urine test that detects the overexpression of the PCA3 gene, an indicator of prostate cancer. [32] [46] [47] [44] ConfirmMDx is performed on tissue taken during a prostate biopsy. The test identifies men with clinically significant prostate cancer who would benefit from further testing and treatment.

3. Shoulder examination - Wikipedia

   en.wikipedia.org/wiki/Shoulder_examination

   A meta-analysis in 2008 concluded that the diagnostic accuracy of individual tests in the shoulder examination was limited, specifically that the Hawkins–Kennedy test and the Speed test have no discriminatory ability to diagnose specific shoulder pathology, and that results of studies evaluating other tests were too statistically ...

4. Yergason's test - Wikipedia

   en.wikipedia.org/wiki/Yergason's_Test

   Yergason's test is a special test used for orthopedic examination of the shoulder and upper arm region, specifically the biceps tendon. [1] Purpose

5. Charity calls for change to prostate cancer testing guidelines

   www.aol.com/charity-calls-change-prostate-cancer...

   At the moment, doctors offer PSA tests to men with prostate cancer symptoms, but cannot proactively offer them to high-risk men with no symptoms, such as men over 50, black men and men with a ...

6. Gleason grading system - Wikipedia

   en.wikipedia.org/wiki/Gleason_grading_system

   The Gleason grading system is used to help evaluate the prognosis of men with prostate cancer using samples from a prostate biopsy. Together with other parameters, it is incorporated into a strategy of prostate cancer staging which predicts prognosis and helps guide therapy. A Gleason score is given to prostate cancer based upon its microscopic ...

7. Active surveillance of prostate cancer - Wikipedia

   en.wikipedia.org/wiki/Active_surveillance_of...

   In a separate study of men from the pre prostate cancer screening era managed with watchful waiting (56% over age 70 years), progression to distant metastasis or prostate cancer death was 13.9% and 12.3%, respectively for Gleason score 6 or below, but considerably higher at 18.2 and 22.7%, 30% and 20%, 44.4% and 55.6% for Gleason 3+4, 4+3, and ...